Novo Nordisk A/S
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +638.1% | -4.9% | -82.2% | +648.7% | +17.2% | +5.0% | -1.4% | +6.3% | +6.0% | +3.0% | +6.4% | |
| – | +591.7% | -16.6% | -78.1% | +665.0% | -17.6% | +8.4% | -6.7% | +11.8% | -5.2% | +2.8% | +17.7% | |
| – | +236.3% | -56.1% | +20.0% | +651.1% | -72.5% | +148.7% | -52.7% | +74.0% | -17.5% | -20.2% | +110.5% | |
| – | +347.3% | -69.2% | -3.2% | +731.6% | -64.9% | +57.9% | -54.4% | +72.1% | -17.3% | -19.8% | +108.0% | |
| – | +879.3% | -4.7% | -86.7% | +627.6% | +25.8% | -1.2% | -0.6% | +7.6% | -18.1% | +32.5% | +8.2% | |
| – | +658.6% | +5.6% | -84.4% | +626.2% | +7.7% | +4.9% | +6.5% | +4.1% | +4.5% | +3.5% | +0.0% | |
| – | – | – | – | – | +35.6% | +6.1% | +4.9% | +6.9% | +7.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | +0.2% | +0.1% | |
| – | +607.1% | +6.6% | -86.6% | +583.1% | +67.1% | +20.2% | -1.4% | -1.2% | +3.4% | -0.2% | -7.1% | |
| – | +607.1% | -3.8% | -81.5% | +650.2% | +16.4% | +8.8% | -10.4% | +9.0% | +1.9% | +2.1% | +4.9% | |
| – | +592.5% | -2.4% | -83.7% | +671.5% | +4.4% | +8.5% | -12.1% | +12.9% | -8.0% | +4.4% | +6.2% | |
| – | +589.9% | +56.9% | -92.3% | +604.5% | +137.6% | +70.9% | -46.6% | +0.6% | -0.1% | +126.4% | -32.6% | |
| – | +797.0% | -49.2% | -67.1% | +463.0% | +19.8% | -32.1% | +44.1% | -15.3% | -17.3% | +578.5% | +15.5% | |
| – | -19.8% | +4.9% | +207.9% | -0.3% | +63.7% | +14.3% | -9.4% | +2.1% | +33.4% | +0.2% | +2.2% | |
| – | +707.1% | -7.2% | -83.7% | +645.3% | +19.1% | -3.4% | +21.3% | +1.1% | +14.2% | +4.6% | +9.0% | |
| – | +704.9% | -5.5% | -83.7% | +654.9% | +18.7% | -4.9% | +19.8% | +2.5% | +15.9% | +5.7% | +8.6% | |
| – | -0.3% | -0.2% | -0.1% | -0.1% | +0.0% | -0.3% | +0.0% | 0.0% | +0.0% | +0.0% | -0.3% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.